Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants
- First Posted Date
- 2021-12-14
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- Sarkana Pharma Inc
- Target Recruit Count
- 16
- Registration Number
- NCT05156034
- Locations
- π³π±
PRA Health Sciences, Groningen, Netherlands
News
No news found